Used as a key intermediate in the synthesis of anticonvulsant drugs, particularly in the production of brivaracetam, a medication for treating partial-onset seizures in epilepsy. The derived drugs like brivaracetam modulate synaptic vesicle protein 2A (SV2A) to enhance neuronal stability by regulating neurotransmitter release. This compound is also employed in pharmaceutical research for developing novel neuroprotective agents, owing to its structural versatility in designing molecules that can efficiently cross the blood-brain barrier.